SciSparc (SPRC) news
Recent news
Scisparc: subsidiary Neurothera Labs completes C$5.4 million financing with Scisparc’s stake valued at approximately C$30 million
Scisparc Inc. has announced that its subsidiary, Neurothera Labs, has successfully completed a C$5.4 million financing round. This development marks a significant milestone for the company, as it reflects growing investor confidence in the biotechnology sector. The financing will be used to advance…
AInvest Wire · Aug 18, 2026Scisparc: subsidiary NeuroThera Labs completed acquisition of CliniqueQuantum
AInvest Wire · Jun 4, 2026Scisparc Ltd: Scisparc: Unit Neurothera Labs received conditional regulatory approval for purchase of Cliniquantum
SciSparc Ltd. (Nasdaq: SPRC) announced that its majority-owned subsidiary, NeuroThera Labs Inc. (TSXV: NTLX), has received conditional regulatory approval for the acquisition of approximately 54.01% of CliniQuantum Ltd. The transaction, valued at approximately $9.46 million, involves issuance of…
AInvest Wire · May 28, 2026Star Petroleum 1Q net income 7.37B baht
Star Petroleum Refining Public Company Limited (SPRC) reported a net income of 7.37 billion baht for the first quarter of 2023, according to its Q1 2023 performance report. This figure reflects the company's financial performance during the period, which was influenced by a range of operational and…
AInvest Wire · May 14, 2026ImportantSciSparc shares up 15% premarket after Co. submited an investigational new drug application with the FDA for its Tourette syndrome-focused treatment
SciSparc shares up 15% premarket after Co. submited an investigational new drug application with the FDA for its Tourette syndrome-focused treatment Introduction: In a significant development for the biotech sector, SciSparc (SCSP) reported a 15% surge in its shares before the market opened on…
AInvest Wire · Aug 26, 2024Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.